# Daiichi Sankyo Co., Ltd.

Organization · id `cardio:org-daiichi-sankyo-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Daiichi+Sankyo+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Daiichi Sankyo Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (`cardio:ct-nct01962545`)
- Sponsors: Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes (`cardio:ct-nct02222350`)
- Sponsors: Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension (`cardio:ct-nct02722265`)
- Sponsors: Study of DU-176b Aged 80 Years or Older (`cardio:ct-nct02801669`)
- Sponsors: Study of CS-3150 in Patients With Essential Hypertension (`cardio:ct-nct02890173`)
- Sponsors: STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study (`cardio:ct-nct03777631`)

## Provenance

Content hash: 73a363de0630e33622bf79639c425e564f5028c83cf7bc5fae710fa3372ed13f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
